Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
British Journal of Haematology|February 23, 2018
Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment-free and overall survival in Chronic Lymphocytic LeukaemiaKyle R Crassini, Eva Zhang, Shalini Balendran, et al.Leukemia & Lymphoma|September 13, 2019
Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantationMaansi Joshi, John Taper, Cecily Forsyth, et al.British Journal of Haematology|October 2, 2014
The oral iron chelator deferasirox inhibits NF-κB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemiaAshish Banerjee, Nicole A Mifsud, Robert Bird, et al.Journal of Clinical Pathology|April 10, 2016
Dysregulation of the intrinsic apoptotic pathway mediates megakaryocytic hyperplasia in myeloproliferative neoplasmsJacques A J Malherbe, Kathryn A Fuller, Bob Mirzai, et al.Acta Haematologica|January 30, 2024
Attitudes towards COVID-19 Vaccination in Adults with Haematological MalignanciesRichard Blennerhassett, Nada Hamad, Lisa Grech, et al.BMC Medical Genetics|February 19, 2020
Two monogenic disorders masquerading as one: severe congenital neutropenia with monocytosis and non-syndromic sensorineural hearing lossParvathy Venugopal, Lucia Gagliardi, Cecily Forsyth, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2018
Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk FeaturesAnna L Godfrey, Peter J Campbell, Cathy MacLean, et al.British Journal of Haematology|February 16, 2017
Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite studyHang Quach, Liam Fernyhough, Ross Henderson, et al.Internal Medicine Journal|May 3, 2025
Outcomes of allogeneic haemopoietic transplant for chronic lymphocytic leukaemia in the modern eraLuani Barge, Steven Tran, Glen Kennedy, et al.Blood Advances|April 5, 2019
The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemiaAdrian G Minson, Katherine Cummins, Lucy Fox, et al.Pageof 4